Clinical Trial Update: A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) [Phase 3]

View source ↗

Summary

Phase 3 REAL4 trial comparing weekly somapacitan to daily Norditropin in children with growth hormone deficiency; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency in Children

Drugs mentioned

• Norditropin (somatropin)
• Somapacitan (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Deficiency in Children | Phase 3 | Status: COMPLETED | Results posted: 2023-08-04